Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Recruiting · NCT06128148 · Registry updated 2025-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors | Neoplasms by Site, Thoracic Neoplasms, brain disorder, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2025-07-14 | NCT06128148 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangzhou JOYO Pharma Co., Ltd | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |